A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Clinical trial NCT00722358 · COMPLETED

Trial details

NCT number: NCT00722358
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2008-12-01
Primary completion: 2009-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.